ClinicalTrialsFinder

Malignant Peritoneal Mesothelioma, Advanced Clinical Trials in Beijing

1 recruitingBeijing, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM

Malignant Peritoneal Mesothelioma, Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences28 enrolled1 locationNCT06543069